Pralmorelin-impurities | Pharmaffiliates

Pralmorelin

Pralmorelin is an orally-active, synthetic peptide drug. It was also under investigation for the treatment of GHD and short stature (pituitary dwarfism). Reference standards of Pralmorelin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Pralmorelin - API Standards
    [catalogue_number] => PA 16 3980000
    [category_ids] => ,70,78,97,114,
    [chemical_name] => 
    [weight] => 817.99
    [form] => C45H55N9O6
    [cas] => 158861-67-7
    [pslug] => 158861-67-7-pralmorelin-api-standards-pa163980000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 3980000

Pralmorelin - API Standards


  • Catalogue No.:PA 16 3980000

  • CAS :

    158861-67-7

  • Molecular Formula : C45H55N9O6

  • Molecular Weight : 817.99

stdClass Object
(
    [pname] => Hexapeptide-2
    [catalogue_number] => PA 16 3981000
    [category_ids] => ,70,78,97,114,
    [chemical_name] => 
    [weight] => 873.03
    [form] => C46H56N12O6
    [cas] => 87616-84-0
    [pslug] => 87616-84-0-hexapeptide-2-pa163981000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 3981000

Hexapeptide-2


  • Catalogue No.:PA 16 3981000

  • CAS :

    87616-84-0

  • Molecular Formula : C46H56N12O6

  • Molecular Weight : 873.03